Cited by 222Virus-based gene therapy researchRNA Interference and Gene DeliveryCRISPR and Genetic Engineering

The DOI matches its Crossref record; 151 of the 152 references it cites were found in a registry or an index.

Integration-deficient Lentiviral Vectors: A Slow Coming of Age

Open access

Wanisch, Klaus, Yáñez-Muñoz, Rafael J·2009·Molecular Therapy

DOI 10.1038/mt.2009.122PMC PMC2835240

Open this paper in CoChat — free account

Abstract

Lentiviral vectors are very efficient at transducing dividing and quiescent cells, which makes them highly useful tools for genetic analysis and gene therapy. Traditionally this efficiency was considered dependent on provirus integration in the host cell genome; however, recent results have challenged this view. So called integration-deficient lentiviral vectors (IDLVs) can be produced through the use of integrase mutations that specifically prevent proviral integration, resulting in the generation of increased levels of circular vector episomes in transduced cells. These lentiviral episomes lack replication signals and are gradually lost by dilution in dividing cells, but are stable in quiescent cells. Compared to integrating lentivectors, IDLVs have a greatly reduced risk of causing insertional mutagenesis and a lower risk of generating replication-competent recombinants (RCRs). IDLVs can mediate transient gene expression in proliferating cells, stable expression in nondividing cells in vitro and in vivo, specific immune responses, RNA interference, homologous recombination (gene repair, knock-in, and knock-out), site-specific recombination, and transposition. IDLVs can be converted into replicating episomes, suggesting that if a clinically applicable system can be developed they would also become highly appropriate for stable transduction of proliferating tissues in therapeutic applications.

Integrity signals

Registry

Crossref · 10.1038/mt.2009.122

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain.
Kim, Y. G., Cha, J., & Chandrasegaran, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1156 · Cited by 1,889
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867
Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery
Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, A., Quiroz, D., Naldini, L., & Trono, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9873-9880.1998 · Cited by 1,815
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C. C., Horn, S. T., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., et al. (1996) · Science · doi:10.1126/science.274.5286.373 · Cited by 1,769

Show all 152 references

Sorted by citations

Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Therapeutic in vivo delivery of gene editing agents
Raguram, A., Banskota, S., & Liu, D. R. (2022) · Cell · doi:10.1016/j.cell.2022.03.045 · Cited by 552
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
Wang, S.-W., Gao, C., Zheng, Y.-M., Yi, L., Lu, J.-C., Huang, X.-Y., Cai, J.-B., Zhang, P.-F., Cui, Y.-H., & Ke, A.-W. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01518-8 · Cited by 478
Recent Advances in Lentiviral Vector Development and Applications
Mátrai, J., Chuah, M., & VandenDriessche, T. (2010) · Molecular Therapy · doi:10.1038/mt.2009.319 · Cited by 365
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells
Holkers, M., Maggio, I., Liu, J., Janssen, J. M., Miselli, F., Mussolino, C., Recchia, A., Cathomen, T., & Gonçalves, M. A. F. V. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1446 · Cited by 312
Engineered materials for in vivo delivery of genome-editing machinery
Tong, S., Moyo, B., Lee, C. M., Leong, K. W., & Bao, G. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0145-9 · Cited by 208
Engineered Viruses as Genome Editing Devices
Chen, X., & Gonçalves, M. A. F. V. (2015) · Molecular Therapy · doi:10.1038/mt.2015.164 · Cited by 154
Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing
Ortinski, P. I., O’Donovan, B., Dong, X., & Kantor, B. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.04.002 · Cited by 146
Adenoviral vector DNA for accurate genome editing with engineered nucleases
Holkers, M., Maggio, I., Henriques, S. F. D., Janssen, J. M., Cathomen, T., & Gonçalves, M. A. F. V. (2014) · Nature Methods · doi:10.1038/nmeth.3075 · Cited by 138
Transformation-associated recombination (TAR) cloning for genomics studies and synthetic biology
Kouprina, N., & Larionov, V. (2016) · Chromosoma · doi:10.1007/s00412-016-0588-3 · Cited by 127
Nonintegrating Gene Therapy Vectors
Athanasopoulos, T., Munye, M. M., & Yáñez‐Muñoz, R. J. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.06.007 · Cited by 134
Self-citation
Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine
Khoshandam, M., Soltaninejad, H., Mousazadeh, M., Hamidieh, A. A., & Hosseinkhani, S. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.027 · Cited by 136
Lentiviral vectors, two decades later
Naldini, L., Trono, D., & Verma, I. M. (2016) · Science · doi:10.1126/science.aah6192 · Cited by 129
Clinical applications of retinal gene therapy
Lipinski, D. M., Thake, M., & MacLaren, R. E. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.09.001 · Cited by 123
Human artificial chromosomes for gene delivery and the development of animal models
Kazuki, Y., & Oshimura, M. (2011) · Molecular Therapy · doi:10.1038/mt.2011.136 · Cited by 108
Emerging Gene Therapies for Genetic Hearing Loss
Ahmed, H., Shubina-Oleinik, O., & Holt, J. R. (2017) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-017-0634-8 · Cited by 105
Ocular gene delivery using lentiviral vectors
Balaggan, K. S., & Ali, R. R. (2011) · Gene Therapy · doi:10.1038/gt.2011.153 · Cited by 108
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases
Kerzel, T., Giacca, G., Beretta, S., Bresesti, C., Notaro, M., Scotti, G. M., Balestrieri, C., Canu, T., Redegalli, M., Pedica, F., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.09.014 · Cited by 102
The Promise and the Hope of Gene Therapy
Papanikolaou, E., & Bosio, A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.618346 · Cited by 101
Immunization delivered by lentiviral vectors for cancer and infectious diseases
Hu, B., Tai, A., & Wang, P. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00967.x · Cited by 88
Enhanced Efficacy of the CDNF/MANF Family by Combined Intranigral Overexpression in the 6-OHDA Rat Model of Parkinson's Disease
Llana, O. C., Houghton, B. C., Rinaldi, F., Taylor, H., Yáñez‐Muñoz, R. J., Uney, J. B., Wong, L., & Caldwell, M. A. (2014) · Molecular Therapy · doi:10.1038/mt.2014.206 · Cited by 85
Self-citation
Zinc-Finger Nucleases for Somatic Gene Therapy: The Next Frontier
Rahman, S. H., Maeder, M. L., Joung, J. K., & Cathomen, T. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.087 · Cited by 81
A new generation of human artificial chromosomes for functional genomics and gene therapy
Kouprina, N., Earnshaw, W. C., Masumoto, H., & Larionov, V. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1113-3 · Cited by 77
Different Methods of Delivering CRISPR/Cas9 Into Cells
Chandrasekaran, A. P., Song, M., Kim, K.-S., & Ramakrishna, S. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.05.001 · Cited by 73
Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through
Gurumoorthy, N., Nordin, F., Tye, G. J., Wan Kamarul Zaman, W. S., & Ng, M. H. (2022) · Biomedicines · doi:10.3390/biomedicines10010107 · Cited by 69
Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair
Izmiryan, A., Ganier, C., Bovolenta, M., Schmitt, A., Mavilio, F., & Hovnanian, A. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.06.008 · Cited by 68
Use of HIV as a gene transfer vector.
Pluta, K. D., & Kacprzak, M. M. (2009) · Acta Biochimica Polonica · doi:10.18388/abp.2009_2490 · Cited by 76
Safety and Biodistribution of an Equine Infectious Anemia Virus-Based Gene Therapy, RetinoStat ® , for Age-Related Macular Degeneration
Binley, K., Widdowson, P. S., Kelleher, M., de Belin, J., Loader, J., Ferrige, G., Carlucci, M., Esapa, M., Chipchase, D., Angell-Manning, D., et al. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.008 · Cited by 61
Human artificial chromosome-based gene delivery vectors for biomedicine and biotechnology
Kouprina, N., Tomilin, A. N., Masumoto, H., Earnshaw, W. C., & Larionov, V. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.882314 · Cited by 60
Design and potential of non-integrating lentiviral vectors
Shaw, A., & Cornetta, K. (2014) · Biomedicines · doi:10.3390/biomedicines2010014 · Cited by 60
LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives
Al-Allaf, F. A., Coutelle, C., Waddington, S. N., David, A. L., Harbottle, R. P., & Themis, M. (2010) · International Archives of Medicine · doi:10.1186/1755-7682-3-36 · Cited by 60
Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors
Merienne, N., Douce, J. L., Faivre, E., Déglon, N., & Bonvento, G. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00106 · Cited by 58
AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa
Wu, Y., Wan, X., Zhao, D., Chen, X., Wang, Y., Tang, X., Li, J., Li, S., Sun, X., Bi, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40655-6 · Cited by 59
Histone Deacetylase Inhibition Activates Transgene Expression from Integration-Defective Lentiviral Vectors in Dividing and Non-Dividing Cells
Pelascini, L. P. L., Janssen, J. M., & Gonçalves, M. A. F. V. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.069 · Cited by 59
Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
Uchida, N., Drysdale, C. M., Nassehi, T., Gamer, J., Yapundich, M., DiNicola, J., Shibata, Y., Hinds, M., Gudmundsdottir, B., Haro-Mora, J. J., et al. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.02.022 · Cited by 55
Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles
Yu, K., Natanson, H., & Dunbar, C. E. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.107 · Cited by 59
Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
Germino-Watnick, P., Hinds, M., Le, A., Chu, R., Liu, X., & Uchida, N. (2022) · Cells · doi:10.3390/cells11111843 · Cited by 63
Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect
Chuang, Y.-F., Phipps, A. J., Lin, F., Hecht, V. F. G., Hewitt, A. W., Wang, P., & Liu, G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03725-2 · Cited by 53
Delivery systems of CRISPR/Cas9-based cancer gene therapy
Biagioni, A., Laurenzana, A., Margheri, F., Chillà, A., Fibbi, G., & Rosso, M. D. (2018) · Journal of Biological Engineering · doi:10.1186/s13036-018-0127-2 · Cited by 52
The Chromatin Structure of CRISPR-Cas9 Target DNA Controls the Balance between Mutagenic and Homology-Directed Gene-Editing Events
Janssen, J. M., Chen, X., Liu, J., & Gonçalves, M. A. F. V. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.02.009 · Cited by 55
Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration
Luo, B., Zhan, Y., Luo, M., Dong, H., Liu, J., Lin, Y., Zhang, J., Wang, G., Verhoeyen, E., Zhang, Y., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03187-1 · Cited by 51
A guide to the optogenetic regulation of endogenous molecules
Manoilov, K. Y., Verkhusha, V. V., & Shcherbakova, D. M. (2021) · Nature Methods · doi:10.1038/s41592-021-01240-1 · Cited by 54
Retroviral Vectors: Post Entry Events and Genomic Alterations
Nowrouzi, A., Glimm, H., Kalle, C. V., & Schmidt, M. (2011) · Viruses · doi:10.3390/v3050429 · Cited by 48
Retroviral Vectors for Gene Therapy
Maier, P., Kalle, C. V., & Laufs, S. (2010) · Future Microbiology · doi:10.2217/fmb.10.100 · Cited by 51
Histones Are Rapidly Loaded onto Unintegrated Retroviral DNAs Soon after Nuclear Entry
Wang, G. Z., Wang, Y., & Goff, S. P. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.10.009 · Cited by 47
Lentiviral vectors for ocular gene therapy
Arsenijevic, Y., Berger, A., Udry, F., & Kostic, C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081605 · Cited by 47
Gene therapy and editing: Novel potential treatments for neuronal channelopathies
Wykes, R. C., & Lignani, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.029 · Cited by 51
Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity
Hu, B., Dai, B., & Wang, P. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.012 · Cited by 45
Integration-deficient Lentiviral Vectors Expressing Codon-optimized R338L Human FIX Restore Normal Hemostasis in Hemophilia B Mice
Suwanmanee, T., Hu, G., Gui, T., Bartholomae, C. C., Kutschera, I., Kalle, C. V., Schmidt, M., Monahan, P. E., & Kafri, T. (2013) · Molecular Therapy · doi:10.1038/mt.2013.188 · Cited by 44
Genotoxicity of retroviral hematopoietic stem cell gene therapy
Trobridge, G. D. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.562496 · Cited by 45
Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
Gallinaro, A., Borghi, M., Bona, R., Grasso, F., Calzoletti, L., Palladino, L., Cecchetti, S., Vescio, M. F., Macchia, D., Morante, V., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00171 · Cited by 43
Targeted gene therapies: tools, applications, optimization
Humbert, O., Davis, L., & Maizels, N. (2012) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2012.658112 · Cited by 45
The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups
Song, M. (2017) · Biotechnology Progress · doi:10.1002/btpr.2484 · Cited by 46
Gene Therapy of ABCA4-Associated DiseasesPreprint
Auricchio, A., Trapani, I., & Allikmets, R. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017301 · Cited by 42
Efficient gene expression from integration-deficient lentiviral vectors in the spinal cord
Peluffo, H., Foster, E., Ahmed, S. G., Lago, N., Hutson, T. H., Moon, L., Yip, P., Wanisch, K., Caraballo-Miralles, V, Olmos, G., et al. (2013) · Gene Therapy · doi:10.1038/gt.2012.78 · Cited by 40
Self-citation
Optimization of Lentiviral Vectors Generation for Biomedical and Clinical Research Purposes: Contemporary Trends in Technology Development and Applications
Kumar, P., & Chan, W. (2011) · Current Gene Therapy · doi:10.2174/156652311794940782 · Cited by 42
Long-Term Episomal Transgene Expression from Mitotically Stable Integration-Deficient Lentiviral Vectors
Kymäläinen, H., Appelt, J. U., Giordano, F. A., Davies, A. F., Ogilvie, C. M., Ahmed, S., Laufs, S., Schmidt, M., Bode, J., Yáñez‐Muñoz, R. J., et al. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.172 · Cited by 38
Self-citation
Advanced gene nanocarriers/scaffolds in nonviral-mediated delivery system for tissue regeneration and repair
Zhang, W., Hou, Y., Yin, S., Miao, Q., Lee, K., Zhou, X., & Wang, Y. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02580-8 · Cited by 43
S/MAR sequence confers long-term mitotic stability on non-integrating lentiviral vector episomes without selection
Verghese, S. C., Goloviznina, N. A., Skinner, A. M., Lipps, H. J., & Kurre, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku082 · Cited by 38
Recent progress in lentiviral vector mass production
Ansorge, S., Henry, O., & Kamen, A. (2009) · Biochemical Engineering Journal · doi:10.1016/j.bej.2009.10.017 · Cited by 37
A portable BRCA1-HAC (human artificial chromosome) module for analysis of BRCA1 tumor suppressor function
Kononenko, A. V., Bansal, R., Lee, N., Grimes, B. R., Masumoto, H., Earnshaw, W. C., Larionov, V., & Kouprina, N. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku870 · Cited by 36
Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques
Negri, D. R. M., Blasi, M., LaBranche, C. C., Parks, R., Balachandran, H., Lifton, M. A., Shen, X., Denny, T. N., Ferrari, G., Vescio, M. F., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.123 · Cited by 35
Transduction of Human Antigen-Presenting Cells with Integrase-Defective Lentiviral Vector Enables Functional Expansion of Primed Antigen-Specific CD8 + T Cells
Negri, D. R. M., Bona, R., Michelini, Z., Leone, P., Macchia, I., Klotman, M. E., Salvatore, M., & Cara, A. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.200 · Cited by 34
Integrase-Deficient Lentiviral Vectors Mediate Efficient Gene Transfer to Human Vascular Smooth Muscle Cells with Minimal Genotoxic Risk
Chick, H. E., Nowrouzi, A., Fronza, R., McDonald, R. A., Kane, N. M., Alba, R., Delles, C., Sessa, W. C., Schmidt, M., Thrasher, A. J., et al. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.042 · Cited by 34
Manufacturing of viral vectors: part II. Downstream processing and safety aspects
Merten, O.-W., Schweizer, M., Chahal, P. S., & Kamen, A. (2014) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.14.15 · Cited by 33
Genetic engineering including superseding microinjection: new ways to make GM pigs
Galli, C., Perota, A., Brunetti, D., Lagutina, I., Lazzari, G., & Lucchini, F. (2010) · Xenotransplantation · doi:10.1111/j.1399-3089.2010.00590.x · Cited by 33
A Nonintegrative Lentiviral Vector-Based Vaccine Provides Long-Term Sterile Protection against Malaria
Coutant, F., Sanchez David, R. Y., Félix, T., Boulay, A., Caleechurn, L., Souque, P., Thouvenot, C., Bourgouin, C., Beignon, A.-S., & Charneau, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048644 · Cited by 32
Lentiviral vectors for immunization: an inflammatory field
Pincha, M., Sundarasetty, B. S., & Stripecke, R. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.9 · Cited by 33
Lentiviral Vectors: A Versatile Tool to Fight Cancer
Emeagi, P. U., Goyvaerts, C., Maenhout, S. K., Pen, J. J., Thielemans, K., & Breckpot, K. (2013) · Current Molecular Medicine · doi:10.2174/1566524011313040011 · Cited by 31
Lentiviral Vector-Mediated RNA Silencing in the Central Nervous System
Hutson, T. H., Foster, E., Moon, L. D. F., & Yáñez‐Muñoz, R. J. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.016 · Cited by 32
Self-citation
Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity
Negri, D. R. M., Michelini, Z., Bona, R., Blasi, M., Filati, P., Leone, P., Rossi, A., Franco, M., & Cara, A. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.571670 · Cited by 32
New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer
Ahmed, M., Daoud, G. H., Mohamed, A., & Harati, R. (2021) · Genes · doi:10.3390/genes12050723 · Cited by 31
Stable expression of large transgenes via the knock-in of an integrase-deficient lentivirus
Chavez, M., Rane, D. A., Chen, X., & Qi, L. S. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01037-x · Cited by 30
Gene and cell therapy based treatment strategies for inflammatory bowel diseases
van der Marel, S. (2011) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v2.i6.114 · Cited by 30
Emerging technology has a brilliant future: the CRISPR-Cas system for senescence, inflammation, and cartilage repair in osteoarthritis
Jia, S., Liang, R., Chen, J., Liao, S., Lin, J., & Li, W. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00581-x · Cited by 34
The HIV-1 Rev/RRE system is required for HIV-1 5' UTR cis elements to augment encapsidation of heterologous RNA into HIV-1 viral particles
Cockrell, A. S., van Praag, H., Santistevan, N. J., Ma, H., & Kafri, T. (2011) · Retrovirology · doi:10.1186/1742-4690-8-51 · Cited by 29
Respiratory Syncytial Virus Engineered To Express the Cystic Fibrosis Transmembrane Conductance Regulator Corrects the Bioelectric Phenotype of Human Cystic Fibrosis Airway Epithelium In Vitro
Kwilas, A. R., Yednak, M. A., Zhang, L., Liesman, R. M., Collins, P. L., Pickles, R. J., & Peeples, M. E. (2010) · Journal of Virology · doi:10.1128/jvi.00346-10 · Cited by 30
Gene Therapy for Inherited Hearing Loss: Updates and Remaining Challenges
Hahn, R., & Avraham, K. B. (2023) · Audiology Research · doi:10.3390/audiolres13060083 · Cited by 29
Gene Therapy to Improve Pancreatic Islet Transplantation for Type 1 Diabetes Mellitus
Hughes, A., Jessup, C. F., Drogemuller, C., Mohanasundaram, D., Milner, C. R., Rojas, D., Russ, G. R., & Coates, P. T. H. (2010) · Current Diabetes Reviews · doi:10.2174/157339910793360897 · Cited by 28
Integration-deficient lentivectors: an effective strategy to purify and differentiate human embryonic stem cell-derived hepatic progenitors
Yang, G., Si-Tayeb, K., Corbineau, S., Vernet, R., Gayon, R., Dianat, N., Martinet, C., Clay, D., Goulinet-Mainot, S., Tachdjian, G., et al. (2013) · BMC Biology · doi:10.1186/1741-7007-11-86 · Cited by 26
Therapeutic genome engineering via CRISPR ‐Cas systems
Moreno, A. M., & Mali, P. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1380 · Cited by 25
Skeletal Muscle Is an Antigen Reservoir in Integrase-Defective Lentiviral Vector-Induced Long-Term Immunity
Lin, Y.-Y., Belle, I., Blasi, M., Huang, M.-N., Buckley, A. F., Rountree, W., Klotman, M. E., Cara, A., & Negri, D. R. M. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.03.008 · Cited by 28
The Novel Replication-defective Vaccinia Virus (Tiantan Strain)–based Hepatitis C Virus Vaccine Induces Robust Immunity in Macaques
Wen, B., Deng, Y. L., Chen, H., Guan, J., Chuai, X., Ruan, L., Kong, W., & Tan, W. (2013) · Molecular Therapy · doi:10.1038/mt.2013.122 · Cited by 26
Nonintegrating Lentiviral Vector-Based Vaccine Efficiently Induces Functional and Persistent CD8+ T Cell Responses in Mice
Negri, D. R. M., Michelini, Z., Baroncelli, S., Spada, M., Vendetti, S., Bona, R., Leone, P., Klotman, M. E., & Cara, A. (2010) · BioMed Research International · doi:10.1155/2010/534501 · Cited by 25
Delivery methods for site-specific nucleases: Achieving the full potential of therapeutic gene editing
Liu, J., & Shui, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.014 · Cited by 24
Knocking down schistosomes – promise for lentiviral transduction in parasites
Hagen, J., Scheerlinck, J. Y., & Gasser, R. B. (2015) · Trends in Parasitology · doi:10.1016/j.pt.2015.03.009 · Cited by 27
Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: The Right Path towards Therapy
Klinkovskij, A., Shepelev, M. V., Isaakyan, Y. A., Aniskin, D., & Ulasov, I. V. (2023) · Biomedicines · doi:10.3390/biomedicines11123333 · Cited by 24
Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology
Sizemore, R. J., Seeger-Armbruster, S., Hughes, S. M., & Parr‐Brownlie, L. C. (2016) · Journal of Neurophysiology · doi:10.1152/jn.01131.2015 · Cited by 24
Focusing Brain Therapeutic Interventions in Space and Time for Parkinson’s Disease
Little, S. J., & Brown, P. (2014) · Current Biology · doi:10.1016/j.cub.2014.08.002 · Cited by 23
Changing channels in pain and epilepsy: Exploiting ion channel gene therapy for disorders of neuronal hyperexcitability
Snowball, A., & Schorge, S. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.004 · Cited by 23
An integration-defective lentivirus-based resource for site-specific targeting of an edited safe-harbour locus in the human genome
Torres-Ruiz, R., Garcia, A. F. R., Jimenez, M., Rodriguez, S., & Ramírez, J. C. (2014) · Gene Therapy · doi:10.1038/gt.2014.1 · Cited by 22
Transgenic Expression of Human Glial Cell Line-Derived Neurotrophic Factor from Integration-Deficient Lentiviral Vectors is Neuroprotective in a Rodent Model of Parkinson's Disease
Lu‐Nguyen, N., Broadstock, M., Schliesser, M. G., Bartholomae, C. C., Kalle, C. V., Schmidt, M., & Yáñez‐Muñoz, R. J. (2014) · Human Gene Therapy · doi:10.1089/hum.2014.003 · Cited by 24
Self-citation
Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
Negri, D. R. M., Rossi, A., Blasi, M., Michelini, Z., Leone, P., Chiantore, M. V., Baroncelli, S., Perretta, G., Cimarelli, A., Klotman, M. E., et al. (2012) · Retrovirology · doi:10.1186/1742-4690-9-69 · Cited by 23
Induction of Broadly Neutralising HCV Antibodies in Mice by Integration-Deficient Lentiviral Vector-Based Pseudotyped Particles
Deng, Y., Guan, J., Wen, B., Zhu, N., Chen, H., Song, J., Yang, Y., Wang, Y., & Tan, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062684 · Cited by 21
Histone Deacetylase Inhibition Rescues Gene Knockout Levels Achieved with Integrase-Defective Lentiviral Vectors Encoding Zinc-Finger Nucleases
Pelascini, L. P. L., Maggio, I., Liu, J., Holkers, M., Cathomen, T., & Gonçalves, M. A. F. V. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.107 · Cited by 21
Prediction of CRISPR-Cas9 off-target activities with mismatches and indels based on hybrid neural network
Yang, Y., Li, J., Zou, Q., Ruan, Y., & Feng, H. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.018 · Cited by 21
Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges
Taiber, S., & Avraham, K. B. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134527 · Cited by 22
Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines
Tang, N., Zhang, Y., Shen, Z., Yao, Y., & Nair, V. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.0017 · Cited by 22
High-efficiency transduction of spinal cord motor neurons by intrauterine delivery of integration-deficient lentiviral vectors
Ahmed, S., Waddington, S. N., Boza-Moran, M.-G., & Yáñez‐Muñoz, R. J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.029 · Cited by 19
Self-citation
Advances in HIV Gene Therapy
Kitawi, R. C., Ledger, S., Kelleher, A. D., & Ahlenstiel, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052771 · Cited by 18

Authors: Wanisch, K., & Yáñez-Muñoz, R. J.
Affiliations: University of London (GB)
Venue: Molecular Therapy
Publisher: Elsevier BV
Published: 2009-08
Volume: 17
Issue: 8
Pages: 1316-1332
ISSN: 1525-0016 (ISSN-L)
DOI: 10.1038/mt.2009.122
PMC: PMC2835240
OpenAlex: W1976244438
Cited by: 222
References: 152
Citations by year: 2026: 6 · 2025: 7 · 2024: 10 · 2023: 12 · 2022: 12 · 2021: 15 · 2020: 4 · 2019: 8 · 2018: 10 · 2017: 13 · 2016: 14 · 2015: 13 · 2014: 22 · 2013: 19 · 2012: 18
FWCI: 1.76
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 2624 d)
Locations: Molecular Therapy (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords: integrase mutations, proviral integration, insertional mutagenesis, quiescent cells, transient expression, stable transduction, homologous recombination, site-specific recombination, transposition, gene therapy
MeSH terms: Animals, Genetic Vectors, Humans, Mutation, Transduction, Genetic, Lentivirus, Integrases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Integration-deficient Lentiviral Vectors: A Slow Coming of Age

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks